An illustration of the AbClo abdominal fascia closure device applied over an open abdomen model with a wound dressing.

Problems with Open Abdomens

Research shows that almost 1 in 5 open abdomen procedures in the US are left intentionally open and a staggering 38% of these "fail to close". The risks of infection, loss of domain and mortality are significant and costly.
An illustration of the AbClo abdominal fascia closure device applied over an open abdomen model with a wound dressing.

The Solution

AbClo’s patented technology enables physicians to non-invasively prevent lateralization of the abdominal walls and facilitate primary closure in open abdomen cases.
An illustration of the AbClo abdominal fascia closure device applied over an open abdomen model with a wound dressing.

When to Use

AbClo should be used to facilitate closure on any intentionally left open abdomen. It supports and stabilizes the abdominal wall to prevent fascia damage, lateral retraction and loss of domain.
An illustration of the AbClo abdominal fascia closure device applied over an open abdomen model with a wound dressing.

Approvals & Regulatory

AbClo is licenced by Health Canada and the FDA.
An illustration of the AbClo abdominal fascia closure device applied over an open abdomen model with a wound dressing.

Made in Canada

AbClo is manufactured in Toronto by our partner MD Precision/Sonele.

Create your account